Press Releases
Investor Resources
Press Releases
Press Release
Cardiol Therapeutics Announces Filing of 2019 Year-end Financial Statements and MD&AMarch 27, 2020
Press Release
Cardiol Therapeutics Appoints Michael J. Willner, Esq. as Business AdvisorDecember 18, 2019
Press Release
Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to its Board of DirectorsDecember 3, 2019
Press Release
Cardiol Therapeutics comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement AgencyNovember 25, 2019